Introduction to Vitamin B3 (Niacin)
Vitamin B3, also known as niacin or nicotinic acid, is an essential nutrient that plays a crucial role in energy metabolism, cell health, and maintaining healthy skin, nervous system, and digestion (Karpe & Frayn, 2004; Cases et al., 1998). Niacin is naturally found in a wide variety of foods, including meat, poultry, fish, nuts, legumes, grains, and fortified foods (Yates et al., 1998). The recommended daily allowance (RDA) for niacin is 16 mg for adult men and 14 mg for adult women, with a tolerable upper intake level (UL) of 35 mg per day (Institute of Medicine, 1998).
Niacin exists in several forms, including nicotinic acid, nicotinamide (niacinamide), and inositol hexanicotinate. Nicotinic acid is the most common form used in supplements and has been extensively studied for its lipid-modifying effects (Karpe & Frayn, 2004). Nicotinamide, on the other hand, does not have the same lipid-modifying properties but has been investigated for its potential benefits in skin health and other conditions (Surjana et al., 2012; Draelos et al., 2005).
Food Sources and Recommended Intake
Good dietary sources of niacin include (Yates et al., 1998):
- Meat, poultry, and fish
- Nuts and legumes
- Grains and fortified cereals
- Dairy products
- Eggs
The RDA for niacin is based on the amount needed to prevent deficiency and maintain optimal health. Most people can meet their niacin needs through a balanced diet, but some individuals may require supplementation due to increased needs or specific health conditions (Institute of Medicine, 1998).
Niacin Deficiency and Toxicity
Niacin deficiency is rare in developed countries but can lead to a condition called pellagra, characterised by the “4 D’s” – diarrhoea, dermatitis, dementia, and death (Hegyi et al., 2004). Pellagra was more common in the past, particularly in populations relying on corn as a staple food, as corn is low in tryptophan, a precursor to niacin (Hegyi et al., 2004).
Excessive niacin intake from supplements can cause adverse effects, such as skin flushing, itching, and gastrointestinal upset (Guyton et al., 1998). The UL for niacin is set at 35 mg per day to prevent these side effects (Institute of Medicine, 1998). High-dose niacin supplements should only be taken under medical supervision, as they may interact with certain medications and require monitoring for potential liver toxicity (Guyton et al., 1998).
Cardiovascular Benefits of Niacin
Lipid-Modifying Effects
One of the most well-established benefits of niacin is its ability to improve cholesterol levels. Numerous studies have demonstrated that niacin can significantly increase high-density lipoprotein (HDL) cholesterol, lower low-density lipoprotein (LDL) cholesterol, and reduce triglycerides (Goldberg et al., 2000; Knopp et al., 1998; Guyton et al., 1998). These lipid-modifying effects are primarily attributed to the nicotinic acid form of niacin.
High-dose niacin (1-3 grams per day) is an effective treatment for dyslipidemia and has been shown to reduce the risk of cardiovascular events in patients with coronary artery disease (Brown et al., 2001; Canner et al., 1986). In the Coronary Drug Project, a randomised, placebo-controlled trial, niacin supplementation (3 grams per day) significantly reduced non-fatal myocardial infarction and mortality rates over a 15-year follow-up period (Canner et al., 1986).
Combination Therapy with Statins
Niacin is often used in combination with statins, a class of lipid-lowering medications, to achieve more comprehensive lipid management. The combination of niacin and simvastatin has been shown to reduce the risk of cardiovascular events in patients with coronary artery disease (Brown et al., 2001). In this study, the combination therapy led to significant improvements in HDL cholesterol, LDL cholesterol, and triglycerides compared to placebo (Brown et al., 2001).
However, more recent trials have questioned the additional benefit of niacin when added to statin therapy. The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial found no significant reduction in cardiovascular events with extended-release niacin added to statin therapy compared to statin therapy alone (Boden et al., 2011). Similarly, the HPS2-THRIVE (Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events) trial showed no benefit of adding niacin-laropiprant to statin therapy in reducing major vascular events (Landray et al., 2014).
Despite these conflicting results, niacin remains a valuable option for patients who cannot tolerate statins or require additional lipid modification. The decision to use niacin should be individualised based on a patient’s specific lipid profile, cardiovascular risk factors, and treatment goals (Guyton et al., 2013).
Niacin and Cognitive Health
Observational Studies
Several observational studies have suggested that higher dietary niacin intake may be associated with a lower risk of age-related cognitive decline and Alzheimer’s disease. In the Chicago Health and Aging Project, a prospective study of 6,158 older adults, higher dietary niacin intake was associated with a slower rate of cognitive decline over a 6-year period (Morris et al., 2004). Participants in the highest quintile of niacin intake had a 70% lower risk of developing Alzheimer’s disease compared to those in the lowest quintile (Morris et al., 2004).
Similarly, in the Rotterdam Study, a prospective cohort study of 5,395 adults aged 55 years and older, higher dietary niacin intake was associated with a reduced risk of incident Alzheimer’s disease over a mean follow-up of 9.6 years (Engelhart et al., 2002). These findings suggest that adequate niacin intake may play a role in maintaining cognitive function and reducing the risk of neurodegenerative diseases.
Potential Mechanisms and Limitations
The potential mechanisms underlying the cognitive benefits of niacin are not fully understood but may involve its role in energy metabolism, antioxidant defenses, and vascular health (Morris et al., 2004). Niacin has been shown to improve endothelial function and reduce inflammation, factors that may contribute to the development of cognitive impairment and dementia (Kaplon et al., 2014; Ganji et al., 2009).
However, it is important to note that these observational studies do not prove a causal relationship between niacin intake and cognitive health. Randomised controlled trials are needed to determine if niacin supplementation can prevent or treat age-related cognitive decline and Alzheimer’s disease. Additionally, the optimal dose and form of niacin for cognitive health remain to be established.
Skin Health Benefits of Niacinamide
Topical Niacinamide for Skin Disorders
Niacinamide, a form of vitamin B3, has been widely studied for its potential benefits in skin health. When applied topically, niacinamide has been shown to improve skin barrier function, reduce inflammation, and treat various skin conditions, such as acne, rosacea, and hyperpigmentation (Draelos et al., 2005; Shalita et al., 2005; Hakozaki et al., 2002).
In a randomised, double-blind, placebo-controlled trial, a 4% niacinamide moisturiser significantly improved skin barrier function and reduced inflammation in subjects with rosacea (Draelos et al., 2005). Similarly, a 4% niacinamide gel was found to be effective in treating moderate to severe acne vulgaris, with results comparable to 1% clindamycin gel (Shalita et al., 2005).
Niacinamide has also been shown to reduce hyperpigmentation and improve skin texture and tone. In a randomised, double-blind, placebo-controlled trial, a 5% niacinamide moisturiser significantly reduced facial hyperpigmentation and improved skin lightness compared to placebo (Hakozaki et al., 2002).
Oral Niacinamide for Skin Cancer Prevention
In addition to its topical benefits, oral niacinamide supplementation has been investigated for its potential role in skin cancer prevention. In a phase III, double-blind, randomised controlled trial, niacinamide supplementation (500 mg twice daily) significantly reduced the incidence of new non-melanoma skin cancers in high-risk individuals over a 12-month period (Chen et al., 2015).
The protective effects of niacinamide against skin cancer may be attributed to its ability to enhance DNA repair and reduce UV-induced immunosuppression (Surjana et al., 2012). However, more research is needed to confirm the long-term efficacy and safety of niacinamide supplementation for skin cancer prevention.
Other Potential Health Benefits
Niacinamide for Phosphate Control in Chronic Kidney Disease
Niacinamide has been investigated as a potential treatment for hyperphosphatemia in patients with chronic kidney disease. Hyperphosphatemia is a common complication of chronic kidney disease and is associated with increased cardiovascular risk and mortality (Block et al., 2004).
In a randomised, double-blind, placebo-controlled trial, niacinamide supplementation (500 mg twice daily) significantly reduced serum phosphate levels in hemodialysis patients over a 8-week period (Cheng et al., 2006). Similar results were observed in another randomised controlled trial, where extended-release niacinamide (1,500 mg daily) effectively lowered phosphate levels in hemodialysis patients (Sampathkumar et al., 2006).
The mechanism by which niacinamide reduces phosphate levels is not fully understood but may involve inhibition of sodium-phosphate cotransporters in the gastrointestinal tract (Eto et al., 2005). While these findings are promising, larger and longer-term studies are needed to establish the efficacy and safety of niacinamide for phosphate control in chronic kidney disease.
Niacin and Type 1 Diabetes
Preliminary evidence suggests that niacin may have a role in slowing the progression of type 1 diabetes by preserving pancreatic beta-cell function. In a small, randomised controlled trial, nicotinamide supplementation (25 mg/kg daily) significantly improved insulin secretion and metabolic control in newly diagnosed type 1 diabetes patients over a 12-month period (Polo et al., 1998).
The potential protective effects of niacin in type 1 diabetes may be related to its role in NAD biosynthesis and its antioxidant properties (Polo et al., 1998). However, these findings need to be confirmed in larger, well-designed trials before niacin can be recommended as a treatment for type 1 diabetes.
Niacinamide for Arthritis
Some preliminary evidence suggests that niacinamide supplementation may improve symptoms in patients with osteoarthritis. In a small, randomised controlled trial, niacinamide supplementation (3 grams daily) significantly reduced inflammation and improved joint mobility in patients with osteoarthritis of the knee (Jonas et al., 1996).
The anti-inflammatory effects of niacinamide may be mediated by its ability to inhibit pro-inflammatory cytokines and reduce oxidative stress (Miesel et al., 1995). However, more research is needed to confirm these findings and determine the optimal dose and duration of niacinamide supplementation for arthritis.
Safety and Side Effects of Niacin Supplements
Common Side Effects
High-dose niacin supplements are generally well-tolerated but can cause several side effects, including (Guyton et al., 1998):
- Skin flushing and itching
- Gastrointestinal upset (nausea, vomiting, diarrhea)
- Headache
- Dizziness
- Blurred vision
Skin flushing is the most common side effect of niacin supplementation and is caused by the release of prostaglandins, leading to vasodilation and increased blood flow to the skin (Guyton et al., 1998). This side effect is more common with immediate-release niacin and can be minimised by taking niacin with meals, gradually increasing the dose, or using extended-release formulations (Guyton et al., 1998).
Drug Interactions and Precautions
Niacin supplements may interact with several medications, including (Guyton et al., 1998):
- Statins: Combination therapy may increase the risk of myopathy and liver toxicity
- Bile acid sequestrants: May reduce the absorption and efficacy of niacin
- Anticoagulants: Niacin may potentiate the effects of these medications and increase the risk of bleeding
- Diabetes medications: Niacin may worsen glycemic control and require dose adjustments
High-dose niacin supplements should be used with caution in patients with liver disease, peptic ulcer disease, or gout, as niacin may exacerbate these conditions (Guyton et al., 1998). Patients with a history of liver disease should have their liver function monitored regularly while taking niacin supplements.
Tolerable Upper Intake Level
The tolerable upper intake level (UL) for niacin is 35 mg per day for adults (Institute of Medicine, 1998). This UL applies to niacin obtained from supplements and fortified foods and does not include niacin naturally present in foods.
Intake above the UL increases the risk of adverse effects, particularly skin flushing and gastrointestinal upset (Institute of Medicine, 1998). High-dose niacin supplements should only be taken under the supervision of a healthcare provider, as they may require dose adjustments and monitoring for potential side effects and toxicities.
Conclusion
Vitamin B3 (niacin) is an essential nutrient with a wide range of potential health benefits. Its most well-established role is in the management of dyslipidemia, where high-dose niacin has been shown to improve lipid profiles and reduce the risk of cardiovascular events. Niacin may also have neuroprotective effects, with observational studies suggesting that higher dietary niacin intake is associated with a lower risk of age-related cognitive decline and Alzheimer’s disease.
Niacinamide, a form of vitamin B3, has been extensively studied for its benefits in skin health. Topical niacinamide has been shown to improve skin barrier function, reduce inflammation, and treat various skin conditions, such as acne, rosacea, and hyperpigmentation. Oral niacinamide supplementation may also have a role in skin cancer prevention, particularly in high-risk individuals.
Other potential health benefits of niacin and niacinamide include improving phosphate control in chronic kidney disease, slowing the progression of type 1 diabetes, and reducing inflammation in osteoarthritis. However, more research is needed to confirm these findings and establish the optimal dose and duration of supplementation.
While niacin supplements are generally well-tolerated, they can cause side effects such as skin flushing, gastrointestinal upset, and headache. High-dose niacin supplements may also interact with certain medications and should be used with caution in patients with liver disease, peptic ulcer disease, or gout.
In conclusion, vitamin B3 is an important nutrient with a range of potential health benefits. While most people can meet their niacin needs through a balanced diet, supplementation may be warranted for certain medical conditions under the guidance of a healthcare provider. As with any supplement, it is important to consider the potential risks and benefits and to use niacin supplements responsibly and under medical supervision.
Key Highlights and Actionable Tips
- Vitamin B3 (niacin) is an essential nutrient that plays a crucial role in energy metabolism, cell health, and maintaining healthy skin, nervous system, and digestion.
- The recommended daily allowance (RDA) for niacin is 16 mg for adult men and 14 mg for adult women, with a tolerable upper intake level (UL) of 35 mg per day.
- High-dose niacin (1-3 grams per day) is an effective treatment for dyslipidemia and has been shown to reduce the risk of cardiovascular events in patients with coronary artery disease.
- Niacinamide, a form of vitamin B3, has been widely studied for its potential benefits in skin health, including improving skin barrier function, reducing inflammation, and treating various skin conditions such as acne, rosacea, and hyperpigmentation.
- High-dose niacin supplements should only be taken under medical supervision, as they may interact with certain medications and require monitoring for potential liver toxicity.
What are the best dietary sources of niacin?
Good dietary sources of niacin include meat, poultry, fish, nuts, legumes, grains, fortified cereals, dairy products, and eggs. Most people can meet their niacin needs through a balanced diet, but some individuals may require supplementation due to increased needs or specific health conditions.
How does niacin help in managing cardiovascular health?
Niacin has been shown to significantly increase high-density lipoprotein (HDL) cholesterol, lower low-density lipoprotein (LDL) cholesterol, and reduce triglycerides. High-dose niacin (1-3 grams per day) is an effective treatment for dyslipidemia and has been shown to reduce the risk of cardiovascular events in patients with coronary artery disease.
What are the potential cognitive health benefits of niacin?
Observational studies have suggested that higher dietary niacin intake may be associated with a lower risk of age-related cognitive decline and Alzheimer’s disease. The potential mechanisms underlying the cognitive benefits of niacin may involve its role in energy metabolism, antioxidant defenses, and vascular health.
How does niacinamide benefit skin health?
When applied topically, niacinamide has been shown to improve skin barrier function, reduce inflammation, and treat various skin conditions, such as acne, rosacea, and hyperpigmentation. Oral niacinamide supplementation has also been investigated for its potential role in skin cancer prevention.
What are the common side effects and precautions when taking niacin supplements?
High-dose niacin supplements can cause side effects such as skin flushing, itching, gastrointestinal upset, headache, dizziness, and blurred vision. Niacin supplements may interact with several medications, including statins, bile acid sequestrants, anticoagulants, and diabetes medications. High-dose niacin supplements should be used with caution in patients with liver disease, peptic ulcer disease, or gout, as niacin may exacerbate these conditions.
References
Block, G. A., Hulbert-Shearon, T. E., Levin, N. W., & Port, F. K. (2004). Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. American Journal of Kidney Diseases, 43(4), 607-617.
Boden, W. E., Probstfield, J. L., Anderson, T., Chaitman, B. R., Desvignes-Nickens, P., Koprowicz, K., … & Weintraub, W. (2011). Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. New England Journal of Medicine, 365(24), 2255-2267.
Brown, B. G., Zhao, X. Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., … & Albers, J. J. (2001). Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. New England Journal of Medicine, 345(22), 1583-1592.
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986). Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Journal of the American College of Cardiology, 8(6), 1245-1255.
Cases, S., Smith, S. J., Zheng, Y. W., Myers, H. M., Lear, S. R., Sande, E., … & Farese, R. V. (1998). Identification of a gene encoding an acyl CoA: diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proceedings of the National Academy of Sciences, 95(22), 13018-13023.
Chen, A. C., Martin, A. J., Choy, B., Fernández-Peñas, P., Dalziell, R. A., McKenzie, C. A., … & Damian, D. L. (2015). A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine, 373(17), 1618-1626.
Cheng, S. C., Young, D. O., Huang, Y., Delmez, J. A., & Coyne, D. W. (2006). A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clinical Journal of the American Society of Nephrology, 1(6), 1131-1138.
Draelos, Z. D., Ertel, K., & Berge, C. (2005). Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis, 76(2), 135-141.
Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., & Breteler, M. M. (2002). Dietary intake of antioxidants and risk of Alzheimer disease. JAMA, 287(24), 3223-3229.
Eto, N., Miyata, Y., Ohno, H., & Yamashita, T. (2005). Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Nephrology Dialysis Transplantation, 20(7), 1378-1384.
Ganji, S. H., Qin, S., Zhang, L., Kamanna, V. S., & Kashyap, M. L. (2009). Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis, 202(1), 68-75.
Goldberg, A., Alagona Jr, P., Capuzzi, D. M., Guyton, J., Morgan, J. M., Rodgers, J., … & Samuel, P. (2000). Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia. The American Journal of Cardiology, 85(9), 1100-1105.
Guyton, J. R., Blazing, M. A., Hagar, J., Kashyap, M. L., Knopp, R. H., McKenney, J. M., … & Zupan, B. (2000). Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Archives of Internal Medicine, 160(8), 1177-1184.
Guyton, J. R., Slee, A. E., Anderson, T., Fleg, J. L., Goldberg, R. B., Kashyap, M. L., … & Zhao, X. Q. (2013). Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). Journal of the American College of Cardiology, 62(17), 1580-1584.
Hakozaki, T., Minwalla, L., Zhuang, J., Chhoa, M., Matsubara, A., Miyamoto, K., … & Boissy, R. E. (2002). The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology, 147(1), 20-31.
Hegyi, J., Schwartz, R. A., & Hegyi, V. (2004). Pellagra: dermatitis, dementia, and diarrhea. International Journal of Dermatology, 43(1), 1-5.
Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. (1998). Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academies Press (US).
Jonas, W. B., Rapoza, C. P., & Blair, W. F. (1996). The effect of niacinamide on osteoarthritis: a pilot study. Inflammation Research, 45(7), 330-334.
Kaplon, R. E., Gano, L. B., & Seals, D. R. (2014). Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. Journal of Applied Physiology, 116(2), 156-163.
Karpe, F., & Frayn, K. N. (2004). The nicotinic acid receptor—a new mechanism for an old drug. The Lancet, 363(9424), 1892-1894.
Knopp, R. H., Alagona, P., Davidson, M., Goldberg, A. C., Kafonek, S. D., Kashyap, M., … & Sprecher, D. (1998). Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism, 47(9), 1097-1104.
Landray, M. J., Haynes, R., Hopewell, J. C., Parish, S., Aung, T., Tomson, J., … & Collins, R. (2014). Effects of extended-release niacin with laropiprant in high-risk patients. New England Journal of Medicine, 371(3), 203-212.
Miesel, R., Zühlke, C., Kröger, H., & Weser, U. (1995). Copper-containing 5-lipoxygenase. Biochemical and Biophysical Research Communications, 209(3), 869-876.
Morris, M. C., Evans, D. A., Bienias, J. L., Scherr, P. A., Tangney, C. C., Hebert, L. E., … & Aggarwal, N. (2004). Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline. Journal of Neurology, Neurosurgery & Psychiatry, 75(8), 1093-1099.
Polo, V., Saibene, A., Pontiroli, A. E., Fermo, I., Ippolito, S., Sergi, G., … & Pozza, G. (1998). Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas. Acta Diabetologica, 35(1), 61-64.
Sampathkumar, K., Selvam, M., Sooraj, Y. S., Gowthaman, S., & Ajeshkumar, R. N. (2006). Extended release nicotinic acid-a novel oral agent for phosphate control. International Urology and Nephrology, 38(1), 171-174.
Shalita, A. R., Smith, J. G., Parish, L. C., Sofman, M. S., & Chalker, D. K. (1995). Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. International Journal of Dermatology, 34(6), 434-437.
Surjana, D., Halliday, G. M., & Damian, D. L. (2012). Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin. Carcinogenesis, 34(5), 1144-1149.
Yates, A. A., Schlicker, S. A., & Suitor, C. W. (1998). Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. Journal of the American Dietetic Association, 98(6), 699-706.
